United Therapeutics Corporation: accounts_receivable
| Value | {"amount": 251300000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2018-06-30) |
| Status | current |
| Entity | United Therapeutics Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:44:46.340152+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/10f31c48-751f-4316-8584-4f81ec53d6d2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-18-048533Retrieved: 2026-08-19T10:44:46.340152+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001082554/accounts-receivable/2018-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/10f31c48-751f-4316-8584-4f81ec53d6d2
History
- no predecessors — first report